FDA Approves New Breast Cancer Drug Perjeta

FDA OKs Perjeta for Late-Stage Breast Cancer New Drug Halts Disease Progression for an Average of 18.5 Months WebMD Medical News By Matt McMillen Reviewed by Louise Chang, MD More...

Click here to read the full story.

Post a Comment
 

 
Comments
No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.